MicroMedicine, Inc – Trademark Portfolio

Entity Type: 03

MicroMedicine, Inc holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SORTERRA and MICROMEDICINE. The owner is based in Waltham, MA.

1440 Main Street, Suite 300

Waltham, MA 02451

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MicroMedicine, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (7 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MicroMedicine, Inc have?

MicroMedicine, Inc has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned.

What trademark classes does MicroMedicine, Inc file in?

MicroMedicine, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MicroMedicine, Inc's most well-known trademarks?

MicroMedicine, Inc's registered trademark portfolio includes well-known marks such as SORTERRA and MICROMEDICINE. These are among 3 currently registered trademarks in the portfolio.

What is MicroMedicine, Inc's trademark registration success rate?

MicroMedicine, Inc has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.